Abstract:Summary Autophagy is a cell self-eating process that allows the orderly degradation and recycling of misfolded proteins and damaged organelles through lysosome.It plays a vital role in cells”adaptation to metabolic stress and homeostasis as well as the formation,development and treatment of tumors.Autophagy is a double-edged sword, both suppressing and facilitating tumorigenesis.For example,multiple benign tumors formed in the liver when autophagy gene Atg5 was mosaically deleted in mice.But at the same time,cancer cells can upregulate autophagy to survive under microenvironmental stress, promote tumor dormancy and increase their growth and aggressiveness. Salinomycin is a polyether ionophore antibiotic isolated from Streptomycesalbus.Compared with lasalocid and monensin,salinomycin is less toxic,lower priced and less susceptible to drug resistance,which enables worldwide use to prevent chicken coccidiosis and promote the growth of ruminants.As an antimicrobial drug,salinomycin acts as an ionophore for K+ and Na+ ions and is able to alter cytoplasmic and mitochondrial membrane potentials, thereby inhibiting oxidative phosphorylation.Besides,salinomycin can activate a MutS homolog 1-dependent cell cycle checkpoint,leading to the ultimate death of the coccidial parasites. In 2009,salinomycin was reported to exert a powerful effect on breast cancer stem cells (CSCs),and it reduced the proportion of CSCs by more than 100 folds relative to paclitaxel.Up to now,it has been shown that salinomycin could effectively kill a variety of CSCs and multi-drug resistant cell lines by inhibiting Wnt/β-catenin signaling pathways, curbing cell cycle progression and reversing epithelial-mesenchymal transformation. Anticarcinogen can directly trigger apoptosis,autophagy and necrosis simultaneously.Most of cancer cell lines utilize autophagy to protect themselves from death after treatment with salinomycin. However, inhibiting autophagy through siRNA or PI3K inhibitor partially prevents cell death upon the addition of salinomycin in SW620 cells,indicating that autophagy induced by salinomycin can provoke cell death.The process of autophagy induced by salinomycin is complicated.Salinomycin can activate autophagy through different ways:1) increasing intracellular reactive oxygen species (ROS),partly via ROS-JNK/AMPK signaling pathways;2) triggering mitophagy by damaging mitochondria;3) inducing endoplasmic reticulum stress to activate autophagy via AKT1-mTOR signaling pathway. In addition, salinomycin does not interfere with the autophagosome-lysosome fusion except suppressing autophagic flux at the late stage by diminishing the lysosome activity.Poor microenvironmental conditions,such as hypoxia,elevated interstitial fluid pressure,glycolysis,low pH and inflammatory cell infiltration,are common features of solid tumors,which are closely related to tumor progression,metastasis and therapy.Salinomycin significantly reduces F4/80+ and CD11B+ inflammatory cells of the tumor microenvironment in mice with pulmonary metastasis.Hypoxia,the focus of most studies,is involved in tumor angiogenesis and the generation and maintenance of CSCs.Low pH has a great influence on drug metabolism,rendering multi-drug resistant of the cancer cells.Autophagy is always upregulated in hypoxic and low pH regions of tumors for the metabolic adaptation of cancer cells.The efficiency of hydroxychloroquine,a late-stage autophagy inhibitor by disrupting lysosome acidification under clinical investigation,is strongly impaired in acidic tumor environments due to drug resistance.However,according to a new study,salinomycin could effectively inhibit autophagy flux under conditions of transient and chronic acidosis.This contributed to the elimination of several cancer cell lines and enhanced cytotoxic effects of salinomycin on CSCs.In short,the inhibition of autophagy flux by salinomycin leads to a considerable change in the tumor microenvironment,which makes salinomycin more potent in terms of the antitumor ability and provides new insights into drug combination. In sum, this paper reviews the antitumor mechanism and application of salinomycin in livestock, the relationship between autophagy and tumor,and the mechanism of autophagy induced by salinomycin.

Salinomycin-induced autophagy blocks apoptosis via the ATG3/AKT/mTOR signaling axis in PC-3 cells

Sinomenine Induces Apoptosis of Prostate Cancer Cells by Blocking Activation of Nf-Kappa B

Salinomycin Exerts Anticancer Effects on PC-3 Cells and PC-3-Derived Cancer Stem Cells In Vitro and In Vivo.

Salinomycin triggers endoplasmic reticulum stress through ATP2A3 upregulation in PC-3 cells

Salinomycin Induces Cell Death with Autophagy Through Activation of Endoplasmic Reticulum Stress in Human Cancer Cells.

Salen-Mn Compounds Induces Cell Apoptosis In Human Prostate Cancer Cells Through Promoting Ampk Activity And Cell Autophagy

Salinomycin Activates Amp-Activated Protein Kinase-Dependent Autophagy in Cultured Osteoblastoma Cells: A Negative Regulator Against Cell Apoptosis

Progress and Application of Salinomycin-Induced Cell Autophagy in Anti-Cancer Treatment

Salinomycin Suppresses Tumorigenicity of Liver Cancer Stem Cells and Wnt/Beta-catenin Signaling

Crosstalk between autophagy inhibitor and salidroside-induced apoptosis: A novel strategy for autophagy-based treatment of hepatocellular cancer

Sennoside A induces autophagic death of prostate cancer via inactivation of PI3K/AKT/mTOR axis

Sinularin stabilizes FOXO3 protein to trigger prostate cancer cell intrinsic apoptosis

Antitumor properties of salinomycin on cisplatin-resistant human ovarian cancer cells in vitro and in vivo: involvement of p38 MAPK activation.

Salvianolic Acid B, A Novel Autophagy Inducer, Exerts Antitumor Activity As A Single Agent in Colorectal Cancer Cells

Anticancer Effect of Salidroside Reduces Viability Through Autophagy/pi3k/akt and MMP-9 Signaling Pathways in Human Bladder Cancer Cells

Mechanism of Action of Salinomycin on Growth and Migration in Pancreatic Cancer Cell Lines

Identification of DNA-PKcs As a Primary Resistance Factor of Salinomycin in Osteosarcoma Cells

Effects of salinomycin on human ovarian cancer cell line OV2008 are associated with modulating p38 MAPK

Salinomycin inhibits the growth of colorectal carcinoma by targeting tumor stem cells.

Salinomycin Induces Apoptosis in Cisplatin-Resistant Colorectal Cancer Cells by Accumulation of Reactive Oxygen Species

Inhibition of autophagy promotes apoptosis and enhances anticancer efficacy of adriamycin via augmented ROS generation in prostate cancer cells